{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:01:05Z","timestamp":1648810865173},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.iccl.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T18:15:41Z","timestamp":1346523341000},"page":"421-428","source":"Crossref","is-referenced-by-count":0,"title":["Optimal Anticoagulant Therapy in ST Elevation Myocardial Infarction Interventions"],"prefix":"10.1016","volume":"1","author":[{"given":"Estefania","family":"Oliveros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Isabel","family":"Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Pena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salomon","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Kostela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Rowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Treto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2012.06.002_bib1","series-title":"Global atlas on cardiovascular disease prevention and control","year":"2011"},{"issue":"3","key":"10.1016\/j.iccl.2012.06.002_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2012.06.002_bib3","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1161\/CIRCULATIONAHA.106.173220","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.iccl.2012.06.002_bib4","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/CIRCULATIONAHA.109.192663","volume":"120","author":"Kushner","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.iccl.2012.06.002_bib5","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1161\/CIR.0b013e31823ba622","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.iccl.2012.06.002_bib6","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1161\/01.CIR.96.7.2155","article-title":"Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion\/Occlusion (HERO) Trial Investigators","volume":"96","author":"White","year":"1997","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.iccl.2012.06.002_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iccl.2012.06.002_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/01.CIR.94.5.891","volume":"94","author":"Bode","year":"1996","journal-title":"Circulation"},{"issue":"9296","key":"10.1016\/j.iccl.2012.06.002_bib9","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","article-title":"Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial","volume":"358","author":"White","year":"2001","journal-title":"Lancet"},{"issue":"9272","key":"10.1016\/j.iccl.2012.06.002_bib10","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(00)05059-5","article-title":"Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/IIIa inhibition: the GUSTO V randomised trial","volume":"357","author":"Topol","year":"2001","journal-title":"Lancet"},{"issue":"9282","key":"10.1016\/j.iccl.2012.06.002_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","article-title":"Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction","volume":"358","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iccl.2012.06.002_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial:\u00a0study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"Am Heart J"},{"issue":"9784","key":"10.1016\/j.iccl.2012.06.002_bib13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"issue":"9696","key":"10.1016\/j.iccl.2012.06.002_bib14","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for\u00a0acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial","volume":"374","author":"Mehran","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.iccl.2012.06.002_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ccd.23179","article-title":"Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy","volume":"79","author":"Wohrle","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"issue":"20","key":"10.1016\/j.iccl.2012.06.002_bib16","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2012.06.002_bib17","series-title":"Textbook of STEMI Interventions","author":"Mehta","year":"2010"},{"key":"10.1016\/j.iccl.2012.06.002_bib18","series-title":"Angiomax (bivalirudin) prescribing information","year":"2005"},{"issue":"3","key":"10.1016\/j.iccl.2012.06.002_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ahj.2011.05.019","article-title":"The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction","volume":"162","author":"Kessler","year":"2011","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.iccl.2012.06.002_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCOUTCOMES.111.961938","article-title":"Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database","volume":"5","author":"Pinto","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.iccl.2012.06.002_bib21","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/heartjnl-2011-301323","article-title":"Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb\/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction","volume":"98","author":"Schwenkglenks","year":"2012","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.iccl.2012.06.002_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11239-010-0528-7","article-title":"Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction","volume":"31","author":"Anderson","year":"2011","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"18","key":"10.1016\/j.iccl.2012.06.002_bib23","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/hrt.2011.224709","volume":"97","author":"Koutouzis","year":"2011","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.iccl.2012.06.002_bib24","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jacc.2009.06.021","article-title":"Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial","volume":"54","author":"Dangas","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745812000776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745812000776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T03:29:15Z","timestamp":1542770955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745812000776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S2211745812000776"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2012.06.002","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}